![Eleonora Teplinsky: Registration for the Collaboration for Outcomes Using Social Media in Oncology meeting](https://oncodaily.com/pub/uploads/2024/07/1562904747715-e1721049809343.png)
Eleonora Teplinsky: Registration for the Collaboration for Outcomes Using Social Media in Oncology meeting
The Collaboration for Outcomes Using Social Media in Oncology (COSMO) has organized the second Conference on Social Media in Oncology
-
Using Social Media to Support Diversity, Equity, and Inclusion in Oncology
-
Using Social Media for Research
-
Creating Meaningful Engagement with Advocates, Physicians, and Reputable Sources of Information
-
Exploring the Role of the Digital Opinion Leader
-
Industry Relations, Partnership, and Transparency
-
Physicians, Patient Advocates, Platform Providers, Health Information Providers
Eleonora Teplinsky shared on LinkedIn:
“Registration for the 2024 COSMO Meeting: Collaboration for Outcomes Using Social Media in Oncology is now open! This is the perfect meeting to get more involved in social media research, learn about professional growth and networking online, engage with patient communities and MORE!
Read further.
Source: Eleonora Teplinsky/LinkedIn
Eleonora Teplinsky is a medical oncologist specializing in breast and gynecologic oncology. She is the head of breast and gynecological medical oncology at Valley-Mount Sinai Comprehensive Cancer Care in Paramus, New Jersey, and a clinical assistant professor of medicine at the Icahn School of Medicine at Mount Sinai in New York.
Her clinical and research interests focus on young women with breast cancer, survivorship, exercise oncology, and the use of social media in oncology. She is passionate about oncology education and advocacy on social media and is the host of the INTERLUDE Podcast, where she shares the stories and experiences of those who have been affected by cancer.
Dr. Teplinsky is the co-lead of the The Collaboration for Outcomes using Social Media in Oncology (COSMO) – a social media lab working to provide a venue for social media research in oncology.